Dexcom Inc Stock Last Dividend Paid

DXCM Stock

USD 72.83 1.63 2.19%

DexCom Inc fundamentals help investors to digest information that contributes to DexCom's financial success or failures. It also enables traders to predict the movement of DexCom Stock. The fundamental analysis module provides a way to measure DexCom's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DexCom stock.

Other Current Liab Total Current Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

DexCom Inc Company Last Dividend Paid Analysis

DexCom's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.

Last Dividend

Last Profit Distribution Amount

Total Shares

More About Last Dividend Paid | All Equity Analysis

DexCom Last Dividend Paid Driver Correlations

Understanding the fundamental principles of building solid financial models for DexCom is extremely important. It helps to project a fair market value of DexCom Stock properly, considering its historical fundamentals such as Last Dividend Paid. Since DexCom's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of DexCom's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of DexCom's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Total Current Assets	Retained Earnings	Accounts Payable	Total Liab	Common Stock	Property Plant Equipment	Short Term Investments	Long Term Debt	Net Receivables	Short Term Debt	Current Deferred Revenue	Net Tangible Assets	Total Permanent Equity	Good Will	Capital Surpluse	Treasury Stock	Intangible Assets	Long Term Debt Total	Short Long Term Debt	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.98	0.95	1.0	0.81	0.92	0.99	0.81	0.98	0.98	0.97	0.97	0.38	0.76	1.0	0.81	0.84	0.88	-0.92	0.87	0.85	0.91	0.86	0.96	0.92	0.8
Total Stockholder Equity	0.98		0.89	0.98	0.73	0.88	0.96	0.72	0.94	0.97	0.93	0.92	0.42	0.65	0.99	0.8	0.87	0.92	-0.93	0.81	0.89	0.89	0.81	0.98	0.94	0.7
Net Debt	0.95	0.89		0.93	0.9	0.87	0.97	0.89	0.96	0.96	0.91	0.97	0.35	0.86	0.94	0.68	0.67	0.74	-0.83	0.89	0.7	0.79	0.81	0.88	0.81	0.89
Total Current Assets	1.0	0.98	0.93		0.76	0.93	0.99	0.77	0.95	0.98	0.98	0.96	0.34	0.73	0.99	0.83	0.86	0.9	-0.92	0.83	0.89	0.93	0.87	0.96	0.94	0.75
Retained Earnings	0.81	0.73	0.9	0.76		0.62	0.84	0.88	0.88	0.79	0.75	0.88	0.32	0.94	0.8	0.42	0.42	0.52	-0.69	0.87	0.44	0.54	0.65	0.74	0.62	0.92
Accounts Payable	0.92	0.88	0.87	0.93	0.62		0.92	0.74	0.88	0.9	0.92	0.9	0.34	0.68	0.89	0.9	0.87	0.86	-0.86	0.79	0.83	0.95	0.88	0.86	0.83	0.71
Total Liab	0.99	0.96	0.97	0.99	0.84	0.92		0.85	0.98	0.97	0.97	0.99	0.36	0.82	0.98	0.8	0.8	0.85	-0.91	0.89	0.82	0.9	0.88	0.94	0.89	0.84
Common Stock	0.81	0.72	0.89	0.77	0.88	0.74	0.85		0.89	0.76	0.75	0.91	0.45	0.91	0.78	0.57	0.54	0.56	-0.71	0.95	0.43	0.63	0.71	0.71	0.55	0.99
Property Plant Equipment	0.98	0.94	0.96	0.95	0.88	0.88	0.98	0.89		0.94	0.92	0.99	0.43	0.84	0.97	0.74	0.77	0.81	-0.9	0.93	0.74	0.82	0.82	0.92	0.83	0.88
Short Term Investments	0.98	0.97	0.96	0.98	0.79	0.9	0.97	0.76	0.94		0.95	0.94	0.35	0.71	0.98	0.76	0.8	0.87	-0.89	0.81	0.86	0.88	0.83	0.96	0.93	0.74
Long Term Debt	0.97	0.93	0.91	0.98	0.75	0.92	0.97	0.75	0.92	0.95		0.94	0.15	0.75	0.96	0.83	0.8	0.85	-0.87	0.76	0.86	0.93	0.9	0.91	0.93	0.73
Net Receivables	0.97	0.92	0.97	0.96	0.88	0.9	0.99	0.91	0.99	0.94	0.94		0.37	0.87	0.96	0.77	0.76	0.8	-0.87	0.92	0.73	0.85	0.86	0.9	0.82	0.9
Short Term Debt	0.38	0.42	0.35	0.34	0.32	0.34	0.36	0.45	0.43	0.35	0.15	0.37		0.24	0.37	0.26	0.43	0.39	-0.46	0.64	0.28	0.29	0.18	0.44	0.17	0.45
Current Deferred Revenue	0.76	0.65	0.86	0.73	0.94	0.68	0.82	0.91	0.84	0.71	0.75	0.87	0.24		0.74	0.52	0.42	0.47	-0.63	0.86	0.38	0.59	0.71	0.64	0.53	0.95
Net Tangible Assets	1.0	0.99	0.94	0.99	0.8	0.89	0.98	0.78	0.97	0.98	0.96	0.96	0.37	0.74		0.79	0.83	0.89	-0.92	0.84	0.86	0.88	0.84	0.97	0.93	0.77
Total Permanent Equity	0.81	0.8	0.68	0.83	0.42	0.9	0.8	0.57	0.74	0.76	0.83	0.77	0.26	0.52	0.79		0.9	0.84	-0.75	0.62	0.82	0.91	0.83	0.75	0.76	0.52
Good Will	0.84	0.87	0.67	0.86	0.42	0.87	0.8	0.54	0.77	0.8	0.8	0.76	0.43	0.42	0.83	0.9		0.97	-0.85	0.65	0.92	0.9	0.84	0.88	0.85	0.48
Capital Surpluse	0.88	0.92	0.74	0.9	0.52	0.86	0.85	0.56	0.81	0.87	0.85	0.8	0.39	0.47	0.89	0.84	0.97		-0.88	0.67	0.96	0.9	0.88	0.94	0.93	0.51
Treasury Stock	-0.92	-0.93	-0.83	-0.92	-0.69	-0.86	-0.91	-0.71	-0.9	-0.89	-0.87	-0.87	-0.46	-0.63	-0.92	-0.75	-0.85	-0.88		-0.81	-0.85	-0.87	-0.79	-0.93	-0.87	-0.68
Intangible Assets	0.87	0.81	0.89	0.83	0.87	0.79	0.89	0.95	0.93	0.81	0.76	0.92	0.64	0.86	0.84	0.62	0.65	0.67	-0.81		0.56	0.7	0.72	0.81	0.62	0.95
Long Term Debt Total	0.85	0.89	0.7	0.89	0.44	0.83	0.82	0.43	0.74	0.86	0.86	0.73	0.28	0.38	0.86	0.82	0.92	0.96	-0.85	0.56		0.92	0.82	0.91	0.95	0.4
Short Long Term Debt	0.91	0.89	0.79	0.93	0.54	0.95	0.9	0.63	0.82	0.88	0.93	0.85	0.29	0.59	0.88	0.91	0.9	0.9	-0.87	0.7	0.92		0.89	0.87	0.89	0.59
Long Term Investments	0.86	0.81	0.81	0.87	0.65	0.88	0.88	0.71	0.82	0.83	0.9	0.86	0.18	0.71	0.84	0.83	0.84	0.88	-0.79	0.72	0.82	0.89		0.85	0.84	0.69
Net Invested Capital	0.96	0.98	0.88	0.96	0.74	0.86	0.94	0.71	0.92	0.96	0.91	0.9	0.44	0.64	0.97	0.75	0.88	0.94	-0.93	0.81	0.91	0.87	0.85		0.95	0.69
Net Working Capital	0.92	0.94	0.81	0.94	0.62	0.83	0.89	0.55	0.83	0.93	0.93	0.82	0.17	0.53	0.93	0.76	0.85	0.93	-0.87	0.62	0.95	0.89	0.84	0.95		0.52
Capital Stock	0.8	0.7	0.89	0.75	0.92	0.71	0.84	0.99	0.88	0.74	0.73	0.9	0.45	0.95	0.77	0.52	0.48	0.51	-0.68	0.95	0.4	0.59	0.69	0.69	0.52

Click cells to compare fundamentals

Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.

Competition

Predict DexCom

DexCom Additional Paid In Capital

Additional Paid In Capital

1.32 Billion

At this time, DexCom's Additional Paid In Capital is very stable compared to the past year.

Based on the recorded statements, DexCom Inc has a Last Dividend Paid of 0.0. This indicator is about the same for the Health Care Equipment & Supplies average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

DexCom Last Dividend Paid Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DexCom's direct or indirect competition against its Last Dividend Paid to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DexCom could also be used in its relative valuation, which is a method of valuing DexCom by comparing valuation metrics of similar companies.

DexCom is currently under evaluation in last dividend paid category among its peers.

DexCom ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, DexCom's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to DexCom's managers, analysts, and investors.

Environmental

Governance

Social

DexCom Fundamentals

	Return On Equity	0.32
	Return On Asset	0.0606
	Profit Margin	0.17 %
	Operating Margin	0.15 %
	Current Valuation	29.49 B
	Shares Outstanding	390.6 M
	Shares Owned By Insiders	0.31 %
	Shares Owned By Institutions	96.77 %
	Number Of Shares Shorted	9.36 M
	Price To Earning	245.31 X
	Price To Book	14.85 X
	Price To Sales	7.36 X
	Revenue	3.62 B
	Gross Profit	1.88 B
	EBITDA	916.7 M
	Net Income	541.5 M
	Cash And Equivalents	2.37 B
	Cash Per Share	6.14 X
	Total Debt	2.59 B
	Debt To Equity	1.17 %
	Current Ratio	3.77 X
	Book Value Per Share	5.07 X
	Cash Flow From Operations	748.5 M
	Short Ratio	1.97 X
	Earnings Per Share	1.65 X
	Price To Earnings To Growth	1.18 X
	Target Price	95.31
	Number Of Employees	9.5 K
	Beta	1.17
	Market Capitalization	29.08 B
	Total Asset	6.26 B
	Retained Earnings	1.02 B
	Working Capital	2.87 B
	Current Asset	231.3 M
	Current Liabilities	66.9 M
	Net Asset	6.26 B

About DexCom Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze DexCom Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DexCom using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DexCom Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether DexCom Inc is a strong investment it is important to analyze DexCom's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DexCom's future performance. For an informed investment choice regarding DexCom Stock, refer to the following important reports:

How To Invest In DexCom

Details

Is DexCom Stock a good investment?

Details

What is DexCom's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out DexCom Piotroski F Score and DexCom Altman Z Score analysis.

You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.157

Earnings Share

1.65

Revenue Per Share

10.089

Quarterly Revenue Growth

0.02

Return On Assets

0.0606

The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Dexcom Inc Stock Last Dividend Paid

DexCom Inc Company Last Dividend Paid Analysis

Last Dividend

Last Profit Distribution Amount

Total Shares

DexCom Last Dividend Paid Driver Correlations

DexCom Additional Paid In Capital

Additional Paid In Capital

1.32 Billion

DexCom Last Dividend Paid Peer Comparison

DexCom ESG Sustainability

DexCom Fundamentals

About DexCom Fundamental Analysis

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY